PTC Therapeutics Inc 2022 SR
The report highlights PTC Therapeutics' 2022 progress in corporate social responsibility, focusing on patient advocacy, employee well-being, and environmental stewardship. Key achievements include investing 67% of business operation expenses into R&D and expanding global operations to over 50 countries. The company reported a 90% employee retention rate and achieved 40% female representation on its Board of Directors. Environmental initiatives featured the formation of a Global Environmental Team and a commitment to LEED certification for new facilities. Furthermore, PTC supported the rare disease community through partnerships with over 200 advocacy groups and the STRIVE Awards program.
Company: PTC Therapeutics Inc
Sector: Health Care
Country: United States
Year: 2022
Type: SR
Pages: 51
PTC Therapeutics Inc
Corporate Sustainability Report
The report highlights PTC Therapeutics' 2022 progress in corporate social responsibility, focusing on patient advocacy, employee well-being, and environmental stewardship. Key achievements include investing 67% of business operation expenses into R&D and expanding global operations to over 50 countries. The company reported a 90% employee retention rate and achieved 40% female representation on its Board of Directors. Environmental initiatives featured the formation of a Global Environmental Team and a commitment to LEED certification for new facilities. Furthermore, PTC supported the rare disease community through partnerships with over 200 advocacy groups and the STRIVE Awards program.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees